Fidson Healthcare Plc: Revised Terms of Rights Issue – 750,000,000 Ordinary Shares of N0.50 kobo each at N4.00 per Share, on the Basis of 1 new Ordinary Share for every 2 Ordinary Shares

Further to the Market Bulletin with Reference Number: NSE/RD/LRD/MB2/18/07/05, dated 5 July 2018 on the above subject matter, Dealing Members are hereby notified that Fidson Healthcare Plc (the Company) has obtained the approval of the Securities and Exchange Commission (SEC) to issue a revised Rights Circular with respect to its Rights Issue.

Kindly recall that the initial terms of the Rights Issue were Nine Hundred Million (900,000,000) ordinary shares of Fifty Kobo (N0.50) each at Five Naira (N5.00) per share, on the basis of three (3) new ordinary shares for every five (5) ordinary shares held as at the close of business on Thursday, 5 July 2018.

The revised terms of the Rights Issue as stated in the SEC approved Rights Circular are now Seven Hundred and Fifty Million (750,000,000) ordinary shares of Fifty Kobo (N0.50) each at Four Naira (N4.00) per share on the basis of one (1) new ordinary share for every two (2) ordinary shares held as at 28 December 2018.

About the company

Fidson Healthcare Limited manufactures and sells pharmaceutical and nutraceutical products in Nigeria including over-the-counter, ethical and consumer products. The company produces various drug classes for antacid and ulcer care, anti-diabetic, anti-malaria, anti-diarrhea, anti-psychotic as well as osteo-care, pain relief, colds and flu, thrombo-prophylactics and cardio-vascular products. Fidson Healthcare Limited also produces a range of nutraceuticals (health) products. The company was incorporated in 1995 and its head office is in Shomolu, Nigeria.